Senate health chair tries to redirect GOP ire at Trump's FDA, over slow safety review of abortion pill mifepristone, back at Obama, Biden regulatory changes. Pro-life research group finds ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback